English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51504470    Online Users :  794
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"jia horng kao"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 706-755 of 1180  (24 Page(s) Totally)
<< < 10 11 12 13 14 15 16 17 18 19 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-09-04T05:16:19Z The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma Wang C.-C.; Tseng K.-C.; Tzeng I.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:19Z Artificial intelligence in precision medicine in hepatology Su T.-H.; Wu C.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:18Z Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma Huang S.-C.; Liao S.-H.; Su T.-H.; Jeng Y.-M.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:18Z The metabolic profiles and body composition of lean metabolic associated fatty liver disease Cheng Y.-M.; JIA-HORNG KAO; Wang C.-C.
臺大學術典藏 2021-09-04T05:16:18Z Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:17Z Reply to “Tacrolimus concentrations were not affected by glecaprevir/pibrentasvir treatment for hepatitis C virus infection in an adult living donor liver transplant recipient with uremia” Yu M.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:17Z Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?Y.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:17Z Highlights JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:16Z Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan Chen C.-Y.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Lo C.-C.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Liu C.-J.; Dai C.-Y.; JIA-HORNG KAO; Chuang W.-L.; Lin H.-C.; Yu M.-L.
臺大學術典藏 2019-10-14T05:52:27Z Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus-Associated Hepatocellular Carcinoma Li, Yung-Tsung;Wu, Hui-Lin;Jia-Horng Kao;Cheng, Huei-Ru;Ming-Chih Ho;Wang, Chih-Chiang;Pei-Jer Chen;Ding-Shinn Chen;Chun-Jen Liu; Li, Yung-Tsung; Wu, Hui-Lin; JIA-HORNG KAO; Cheng, Huei-Ru; MING-CHIH HO; Wang, Chih-Chiang; PEI-JER CHEN; DING-SHINN CHEN; CHUN-JEN LIU
臺大學術典藏 2019-10-14T05:52:27Z Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus-Associated Hepatocellular Carcinoma Li, Yung-Tsung;Wu, Hui-Lin;Jia-Horng Kao;Cheng, Huei-Ru;Ming-Chih Ho;Wang, Chih-Chiang;Pei-Jer Chen;Ding-Shinn Chen;Chun-Jen Liu; Li, Yung-Tsung; Wu, Hui-Lin; JIA-HORNG KAO; Cheng, Huei-Ru; MING-CHIH HO; Wang, Chih-Chiang; PEI-JER CHEN; DING-SHINN CHEN; CHUN-JEN LIU
臺大學術典藏 2019-09-09T00:55:30Z Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B Papatheodoridis, George V.; Bansal, Aruna T.; Plesniak, Robert; Liaw, Yun Fan; Motoc, Adriana; Foster, Graham R.; He, Hua; Wei, Lai; JIA-HORNG KAO; JIA-HORNG KAO;Wei, Lai;He, Hua;Foster, Graham R.;Motoc, Adriana;Liaw, Yun Fan;Plesniak, Robert;Bansal, Aruna T.;Papatheodoridis, George V.;Chen, Xiaoping;Piratvisuth, Teerha;Lampertico, Pietro;Wat, Cynthia;Pavlovic, Vedran; Pavlovic, Vedran; Wat, Cynthia; Lampertico, Pietro; Piratvisuth, Teerha; Chen, Xiaoping
臺大學術典藏 2019-09-09T00:55:30Z Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B Papatheodoridis, George V.; Bansal, Aruna T.; Plesniak, Robert; Liaw, Yun Fan; Motoc, Adriana; Foster, Graham R.; He, Hua; Wei, Lai; JIA-HORNG KAO; JIA-HORNG KAO;Wei, Lai;He, Hua;Foster, Graham R.;Motoc, Adriana;Liaw, Yun Fan;Plesniak, Robert;Bansal, Aruna T.;Papatheodoridis, George V.;Chen, Xiaoping;Piratvisuth, Teerha;Lampertico, Pietro;Wat, Cynthia;Pavlovic, Vedran; Pavlovic, Vedran; Wat, Cynthia; Lampertico, Pietro; Piratvisuth, Teerha; Chen, Xiaoping
臺大學術典藏 2019-08-29T07:36:15Z Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy HUNG-CHIH YANG; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-JEN LIU;HUNG-CHIH YANG;Tseng, Tai-Chung;KAI-WEN HUANG;CHEN-HUA LIU;Liao, Chun-Hsun;TUNG-HUNG SU; TUNG-HUNG SU; Liao, Chun-Hsun; CHEN-HUA LIU; KAI-WEN HUANG; Tseng, Tai-Chung
臺大學術典藏 2019-08-29T07:36:15Z Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy HUNG-CHIH YANG; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-JEN LIU;HUNG-CHIH YANG;Tseng, Tai-Chung;KAI-WEN HUANG;CHEN-HUA LIU;Liao, Chun-Hsun;TUNG-HUNG SU; TUNG-HUNG SU; Liao, Chun-Hsun; CHEN-HUA LIU; KAI-WEN HUANG; Tseng, Tai-Chung
臺大學術典藏 2019-08-29T07:31:54Z NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging Tung-Hung Su;Liao, Sih-Han;Chun-Ming Hong;Chun-Jen Liu;Tseng, Tai-Chung;Chen-Hua Liu;Hung-Chih Yang;Pei-Jer Chen;Ding-Shinn Chen;Chi-Ling Chen;Adhoute, Xavier;Bourli?Re, Marc;Jia-Horng Kao; TUNG-HUNG SU; Liao, Sih-Han; CHUN-MING HONG; CHUN-JEN LIU; Tseng, Tai-Chung; CHEN-HUA LIU; HUNG-CHIH YANG; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; Adhoute, Xavier; Bourli?re, Marc; JIA-HORNG KAO
臺大學術典藏 2019-08-29T07:31:54Z NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging Tung-Hung Su;Liao, Sih-Han;Chun-Ming Hong;Chun-Jen Liu;Tseng, Tai-Chung;Chen-Hua Liu;Hung-Chih Yang;Pei-Jer Chen;Ding-Shinn Chen;Chi-Ling Chen;Adhoute, Xavier;Bourli?Re, Marc;Jia-Horng Kao; TUNG-HUNG SU; Liao, Sih-Han; CHUN-MING HONG; CHUN-JEN LIU; Tseng, Tai-Chung; CHEN-HUA LIU; HUNG-CHIH YANG; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; Adhoute, Xavier; Bourli?re, Marc; JIA-HORNG KAO
臺大學術典藏 2019-08-29T07:30:08Z Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection Chen-Hua Liu;Tung-Hung Su;Chun-Jen Liu;Chun-Ming Hong;Hung-Chih Yang;Tseng, Tai-Chung;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; CHEN-HUA LIU; TUNG-HUNG SU; CHUN-JEN LIU; CHUN-MING HONG; HUNG-CHIH YANG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO
臺大學術典藏 2019-08-29T07:30:08Z Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection Chen-Hua Liu;Tung-Hung Su;Chun-Jen Liu;Chun-Ming Hong;Hung-Chih Yang;Tseng, Tai-Chung;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; CHEN-HUA LIU; TUNG-HUNG SU; CHUN-JEN LIU; CHUN-MING HONG; HUNG-CHIH YANG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO
臺大學術典藏 2019-08-29T07:29:17Z Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO
臺大學術典藏 2019-08-29T07:29:17Z Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO
臺大學術典藏 2019-08-29T07:28:24Z Profile and value of FIB-4 in patients with dual chronic hepatitis C and B Yang, Wan-Ting; TUNG-HUNG SU; HUNG-CHIH YANG; CHEN-HUA LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; Tseng, Tai-Chung; CHUN-JEN LIU; Chun-Jen Liu;Tseng, Tai-Chung;Yang, Wan-Ting;Tung-Hung Su;Hung-Chih Yang;Chen-Hua Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao
臺大學術典藏 2019-08-29T07:28:24Z Profile and value of FIB-4 in patients with dual chronic hepatitis C and B Yang, Wan-Ting; TUNG-HUNG SU; HUNG-CHIH YANG; CHEN-HUA LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; Tseng, Tai-Chung; CHUN-JEN LIU; Chun-Jen Liu;Tseng, Tai-Chung;Yang, Wan-Ting;Tung-Hung Su;Hung-Chih Yang;Chen-Hua Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao
臺大學術典藏 2019-08-29T07:26:10Z Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO
臺大學術典藏 2019-08-29T07:26:10Z Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO
臺大學術典藏 2019-08-05T07:28:14Z Reduced toll-like receptor 9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy JIA-HORNG KAO;Yang, Sien-Sing;PING-NING HSU;PEI-JER CHEN;DING-SHINN CHEN;Liang, Cher-Wei;Chang, Han-Yu;Hu, Jui-Ting;SHU-CHEN WEI;Lin, Shih-Chang;Hsu, Cheng-Kai;YI-WEN HUANG; YI-WEN HUANG; Hsu, Cheng-Kai; Lin, Shih-Chang; SHU-CHEN WEI; Hu, Jui-Ting; Chang, Han-Yu; Liang, Cher-Wei; DING-SHINN CHEN; PEI-JER CHEN; PING-NING HSU; Yang, Sien-Sing; JIA-HORNG KAO
臺大學術典藏 2019-08-05T07:28:14Z Reduced toll-like receptor 9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy JIA-HORNG KAO;Yang, Sien-Sing;PING-NING HSU;PEI-JER CHEN;DING-SHINN CHEN;Liang, Cher-Wei;Chang, Han-Yu;Hu, Jui-Ting;SHU-CHEN WEI;Lin, Shih-Chang;Hsu, Cheng-Kai;YI-WEN HUANG; YI-WEN HUANG; Hsu, Cheng-Kai; Lin, Shih-Chang; SHU-CHEN WEI; Hu, Jui-Ting; Chang, Han-Yu; Liang, Cher-Wei; DING-SHINN CHEN; PEI-JER CHEN; PING-NING HSU; Yang, Sien-Sing; JIA-HORNG KAO
臺大學術典藏 2019-08-05T07:20:11Z Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy JIA-HORNG KAO;Yang, Sien-Sing;PING-NING HSU;PEI-JER CHEN;DING-SHINN CHEN;Huang, Shih-Hung;Chang, Han-Yu;Hu, Jui-Ting;SHU-CHEN WEI;Lin, Shih-Chang;YI-WEN HUANG; YI-WEN HUANG; Lin, Shih-Chang; SHU-CHEN WEI; Hu, Jui-Ting; Chang, Han-Yu; Huang, Shih-Hung; DING-SHINN CHEN; PEI-JER CHEN; PING-NING HSU; Yang, Sien-Sing; JIA-HORNG KAO
臺大學術典藏 2019-08-05T07:20:11Z Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy JIA-HORNG KAO;Yang, Sien-Sing;PING-NING HSU;PEI-JER CHEN;DING-SHINN CHEN;Huang, Shih-Hung;Chang, Han-Yu;Hu, Jui-Ting;SHU-CHEN WEI;Lin, Shih-Chang;YI-WEN HUANG; YI-WEN HUANG; Lin, Shih-Chang; SHU-CHEN WEI; Hu, Jui-Ting; Chang, Han-Yu; Huang, Shih-Hung; DING-SHINN CHEN; PEI-JER CHEN; PING-NING HSU; Yang, Sien-Sing; JIA-HORNG KAO
臺大學術典藏 2019-02-27T06:48:01Z Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan Tseng, Tai-Chung;JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;CHEN-HUA LIU; CHEN-HUA LIU; CHUN-JEN LIU; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO
臺大學術典藏 2019-02-27T06:48:01Z Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan Tseng, Tai-Chung;JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;CHEN-HUA LIU; CHEN-HUA LIU; CHUN-JEN LIU; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO
臺大學術典藏 2019-02-27T06:44:06Z Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study Tseng, Tai-Chung;Liu, Wen-Chun;Yang, Sheng-Shun;Chang, Chung-Hsin;Yang, Sien-Sing;Huang, Yi-Jie;JIA-HORNG KAO;CHIEN-CHING HUNG;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;HSIN-YUN SUN;CHEN-HUA LIU; CHEN-HUA LIU; Huang, Yi-Jie; Yang, Sien-Sing; Chang, Chung-Hsin; Yang, Sheng-Shun; HSIN-YUN SUN; CHUN-JEN LIU; Liu, Wen-Chun; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; CHIEN-CHING HUNG; JIA-HORNG KAO
臺大學術典藏 2019-02-27T06:44:06Z Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study Tseng, Tai-Chung;Liu, Wen-Chun;Yang, Sheng-Shun;Chang, Chung-Hsin;Yang, Sien-Sing;Huang, Yi-Jie;JIA-HORNG KAO;CHIEN-CHING HUNG;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;HSIN-YUN SUN;CHEN-HUA LIU; CHEN-HUA LIU; Huang, Yi-Jie; Yang, Sien-Sing; Chang, Chung-Hsin; Yang, Sheng-Shun; HSIN-YUN SUN; CHUN-JEN LIU; Liu, Wen-Chun; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; CHIEN-CHING HUNG; JIA-HORNG KAO
臺大學術典藏 2018-10-09 Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus Hung-Chih Yang;Jia-Horng Kao; HUNG-CHIH YANG; JIA-HORNG KAO
臺大學術典藏 2018-10-09 Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus Hung-Chih Yang;Jia-Horng Kao; HUNG-CHIH YANG; JIA-HORNG KAO
臺大學術典藏 2018-09-10T18:07:03Z Prevention of mother-to-child transmission: the key of hepatitis B virus elimination Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO
臺大學術典藏 2018-09-10T18:07:02Z Review article: the prevention of hepatitis B-related hepatocellular carcinoma C.-L. Lin;J.-H. Kao; JIA-HORNG KAO
臺大學術典藏 2018-09-10T18:07:02Z Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B Chao-Wei Hsu;Wei-Wen Su;Chuan-Mo Lee;Cheng-Yuan Peng;Wan-Long Chuang;Jia-Horng Kao;Heng-Cheng Chu;Yi-Hsiang Huang;Rong-Nan Chien;Yun-Fan Liaw; JIA-HORNG KAO
臺大學術典藏 2018-09-10T18:07:02Z Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B Chao-Wei Hsu;Wei-Wen Su;Chuan-Mo Lee;Cheng-Yuan Peng;Wan-Long Chuang;Jia-Horng Kao;Heng-Cheng Chu;Yi-Hsiang Huang;Rong-Nan Chien;Yun-Fan Liaw; JIA-HORNG KAO
臺大學術典藏 2018-09-10T18:07:02Z Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma Ming-Hung Hu;Tzu-Ting Huang;Tzu-I Chao;Li-Ju Chen;Yen-Lin Chen;Ming-Hsien Tsai;Chun-Yu Liu;Jia-Horng Kao;Kuen-Feng Chen; JIA-HORNG KAO
臺大學術典藏 2018-09-10T18:07:02Z Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma Ming-Hung Hu;Tzu-Ting Huang;Tzu-I Chao;Li-Ju Chen;Yen-Lin Chen;Ming-Hsien Tsai;Chun-Yu Liu;Jia-Horng Kao;Kuen-Feng Chen; JIA-HORNG KAO
臺大學術典藏 2018-09-10T18:07:02Z Preface Kao, J.-H.;Chen, D.-S.; JIA-HORNG KAO
臺大學術典藏 2018-09-10T18:07:02Z Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy Su, T.-H.;Yang, H.-C.;Tseng, T.-C.;Liou, J.-M.;Liu, C.-H.;Chen, C.-L.;Chen, P.-J.;Chen, D.-S.;Liu, C.-J.;Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; JIA-HORNG KAO
臺大學術典藏 2018-09-10T18:07:01Z Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B Papatheodoridis, G.V.;Manolakopoulos, S.;Su, T.-H.;Siakavellas, S.;Liu, C.-J.;Kourikou, A.;Yang, H.-C.;Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; JIA-HORNG KAO
臺大學術典藏 2018-09-10T18:07:01Z Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy Tung-Hung Su;Chun-Hsun Liao;Chen-Hua Liu;Kai-Wen Huang;Tai-Chung Tseng;Hung-Chih Yang;Chun-Jen Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; JIA-HORNG KAO
臺大學術典藏 2018-09-10T18:07:01Z Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy Tung-Hung Su;Chun-Hsun Liao;Chen-Hua Liu;Kai-Wen Huang;Tai-Chung Tseng;Hung-Chih Yang;Chun-Jen Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; JIA-HORNG KAO
臺大學術典藏 2018-09-10T18:05:07Z A noninvasive diagnosis of hepatic fibrosis by BioFibroScoreR in chronic hepatitis C patients HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; CHUN-MING HONG; DING-SHINN CHEN; JIA-HORNG KAO; Liu, C.-H.;Liu, C.-J.;Hong, C.-M.;Su, T.-H.;Yang, H.-C.;Chen, K.-M.;Huang, Y.-P.;Yeh, Y.-M.;Tien, H.-L.;Liu, Y.-C.;Kao, J.-H.;Chen, D.-S.;Chen, P.-J.
臺大學術典藏 2018-09-10T18:04:53Z Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis JIA-HORNG KAO; KAI-WEN HUANG; TUNG-HUNG SU; DING-SHINN CHEN; CHEN-HUA LIU; CHUN-JEN LIU; HUNG-CHIH YANG; Su, T.-H. and Shiau, C.-W. and Jao, P. and Yang, N.-J. and Tai, W.-T. and Liu, C.-J. and Tseng, T.-C. and Yang, H.-C. and Liu, C.-H. and Huang, K.-W. and Hu, T.-C. and Huang, Y.-J. and Wu, Y.-M. and Chen, L.-J. and Chen, P.-J. and Chen, D.-S. and Chen, K.-F. and Kao, J.-H.
臺大學術典藏 2018-09-10T18:03:52Z Strategies to manage hepatitis C virus infection disease burden�XVolume 4 Chen, D.S.;Hamoudi, W.;Mustapha, B.;Layden, J.;Nersesov, A.;Reic, T.;Garcia, V.;Rios, C.;Mateva, L.;Njoya, O.;Al-Busafi, S.A.;Abdelmageed, M.K.;Abdulla, M.;Adda, D.;Akin, O.;Al Baqali, A.;Al Dweik, N.;Al Ejji, K.;Al Ghazzawi, I.;Al Kaabi, S.;Al Naamani, K.;Al Qamish, J.;Al Sadadi, M.;Al Salman, J.;Albadri, M.;Al-Romaihi, H.E.;Ampofo, W.;Antonov, K.;Anyaike, C.;Arome, F.;Bane, A.;Blach, S.;Borodo, M.M.;Brandon, S.M.;Bright, B.;Butt, M.T.;Cardenas, I.;Chan, H.L.Y.;Chen, C.J.;Chen, P.J.;Chien, R.N.;Chuang, W.L.;Cuellar, D.;Derbala, M.;Elbardiny, A.A.;Estes, C.;Farag, E.;Fung, J.;Gamkrelidze, I.;Genov, J.;Ghandour, Z.;Ghuloom, M.;Gomez, B.;Gunter, J.;Habeeb, J.;Hajelssedig, O.;Himatt, S.M.;Hrstic, I.;Hu, C.C.;Huang, C.F.;Hui, Y.T.;Jahis, R.;Jelev, D.;John, A.K.;Kaliaskarova, K.S.;Kamel, Y.;Kao, J.H.;Khamis, J.;Khattabi, H.;Khoudri, I.;Konysbekova, A.;Kotzev, I.;Lai, M.S.;Lao, W.C.;Lee, M.H.;Lesi, O.;Li, M.;Lo, A.;Loo, C.K.;Luk?I?, B.;Maaroufi, A.;Malu, A.O.;Mitova, R.;Mohamed, R.;Morovi?, M.;Murphy, K.;Nde, H.;Ngige, E.;Njouom, R.;Nonkovi?, D.;Obekpa, S.;Oguche, S.;Okolo, E.E.;Omede, O.;Omuemu, C.;Ondoa, P.;Opare-Sem, O.;Owusu-Ofori, S.;Phillips, R.O.;Prokopenko, Y.N.;Razavi, H.;Razavi-Shearer, D.;Razavi-Shearer, K.;Redae, B.;Rinke De Wit, T.;Robbins, S.;Roberts, L.R.;Sanad, S.J.;Sharma, M.;Simonova, M.;Su, T.H.;Sultan, K.;Tan, S.S.;Tchernev, K.;Tsang, O.T.Y.;Tsang, S.;Tzeuton, C.;Ugoeze, S.;Uzochukwu, B.;Vi, R.;Vince, A.;Wani, H.U.;Wong, V.W.S.;Workneh, A.;Yacoub, R.;Yesmembetov, K.I.;Youbi, M.;Yuen, M.F.;Schmelzer, J.D.; DING-SHINN CHEN; JIA-HORNG KAO
臺大學術典藏 2018-09-10T18:03:52Z Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinoma Hu, M.-H.;Chen, L.-J.;Chen, Y.-L.;Tsai, M.-S.;Shiau, C.-W.;Chao, T.-I.;Liu, C.-Y.;Kao, J.-H.;Chen, K.-F.; JIA-HORNG KAO

Showing items 706-755 of 1180  (24 Page(s) Totally)
<< < 10 11 12 13 14 15 16 17 18 19 > >>
View [10|25|50] records per page